{"AllianceGenome": "3059", "HGNC": "3059", "MIM": "126150", "_id": "1839", "_version": 1, "accession": {"genomic": ["AC004634.1", "AY164533.1", "CH471062.2", "CP068273.2", "GM880654.1", "L17029.1", "L17030.1", "L17031.1", "NC_000005.10", "NC_060929.1"], "protein": ["AAA35956.1", "AAA50562.1", "AAA50563.1", "AAA50564.1", "AAC15470.1", "AAH33097.1", "AAN46738.1", "BAD96408.1", "BAG36018.1", "CAV28318.1", "EAW62069.1", "NP_001936.1", "Q99075.1"], "rna": ["AK222688.1", "AK307310.1", "AK313202.1", "BC033097.1", "D55114.1", "M60278.1", "NM_001945.3"], "translation": [{"protein": "BAD96408.1", "rna": "AK222688.1"}, {"protein": "AAA35956.1", "rna": "M60278.1"}, {"protein": "NP_001936.1", "rna": "NM_001945.3"}, {"protein": "BAG36018.1", "rna": "AK313202.1"}, {"protein": "AAH33097.1", "rna": "BC033097.1"}]}, "alias": ["DTR", "DTS", "DTSF", "HEGFL"], "ensembl": {"gene": "ENSG00000113070", "protein": "ENSP00000230990", "transcript": ["ENST00000230990", "ENST00000482211", "ENST00000498452"], "translation": [{"protein": "ENSP00000230990", "rna": "ENST00000230990"}], "type_of_gene": "protein_coding"}, "entrezgene": "1839", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.58338635357, "exp_mis": 75.8699301259, "exp_syn": 34.3352008974, "lof_z": 2.34066100276184, "mis_z": 2.12655236740516, "mu_lof": 3.38573364894e-07, "mu_mis": 6.87262091128e-06, "mu_syn": 3.05806590489e-06, "n_lof": 0.0, "n_mis": 38.0, "n_syn": 34.0, "p_li": 0.830814322298121, "p_null": 0.00350944110668997, "p_rec": 0.165676236595189, "syn_z": 0.0354636676853252}, "bp": 627, "cds_end": 139725913, "cds_start": 139714260, "n_exons": 5, "nonpsych": {"exp_lof": 4.95827699714, "exp_mis": 68.5743836934, "exp_syn": 30.9814461661, "lof_z": 2.1868417888525, "mis_z": 2.16679642338747, "mu_lof": 3.38573364894e-07, "mu_mis": 6.87262091128e-06, "mu_syn": 3.05806590489e-06, "n_lof": 0.0, "n_mis": 33.0, "n_syn": 31.0, "p_li": 0.815321320155619, "p_null": 0.00533353360260719, "p_rec": 0.179345146241774, "syn_z": -0.00209824696804999}, "nontcga": {"exp_lof": 5.12743345643, "exp_mis": 69.7910587155, "exp_syn": 31.5791064302, "lof_z": 2.23373292898125, "mis_z": 2.13444283677092, "mu_lof": 3.38573364894e-07, "mu_mis": 6.87262091128e-06, "mu_syn": 3.05806590489e-06, "n_lof": 0.0, "n_mis": 34.0, "n_syn": 28.0, "p_li": 0.811142404063382, "p_null": 0.00469070511196083, "p_rec": 0.184166890824657, "syn_z": 0.403271375257891}, "transcript": "ENST00000230990.6"}, "exons": [{"cdsend": 140346328, "cdsstart": 140334675, "chr": "5", "position": [[140332842, 140334280], [140334657, 140334748], [140335871, 140336027], [140342634, 140342812], [140345910, 140346084], [140346282, 140346603]], "strand": -1, "transcript": "NM_001945", "txend": 140346603, "txstart": 140332842}], "exons_hg19": [{"cdsend": 139725913, "cdsstart": 139714260, "chr": "5", "position": [[139712427, 139713865], [139714242, 139714333], [139715456, 139715612], [139722219, 139722397], [139725495, 139725669], [139725867, 139726188]], "strand": -1, "transcript": "NM_001945", "txend": 139726188, "txstart": 139712427}], "generif": [{"pubmed": 11761337, "text": "Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/reperfusion injury."}, {"pubmed": 11769972, "text": "Site-directed mutagenesis of heparin-binding EGF-like growth factor (HB-EGF): analysis of O-glycosylation sites and properties"}, {"pubmed": 11920609, "text": "HB-EGF mRNA and protein levels in gastric cancers were elevated, compared with normal gastric tissues, especially in the intestinal type."}, {"pubmed": 11922634, "text": "The current study reveals that HB-EGF mRNA is abundantly expressed in human and mouse adipose tissue, plasma HB-EGF levels increase in parallel with fat accumulation in human, and subjects with coronary artery disease have higher plasma HB-EGF levels."}, {"pubmed": 11943653, "text": "Bronchial epithelial compression regulates MAP kinase signaling and HB-EGF-like growth factor expression."}, {"pubmed": 11983897, "text": "Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells"}, {"pubmed": 12095415, "text": "nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF)"}, {"pubmed": 12099696, "text": "Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF"}, {"pubmed": 12112577, "text": "data suggest that uterine receptivity may be regulated in part by the stromal-derived HB-EGF"}, {"pubmed": 12230876, "text": "HB-EGF cytoprotection is due, in part, to its ability to decrease reactive oxygen species production"}, {"pubmed": 12568494, "text": "Review. The mode of activation of EGFR in response to bacterial lipoteichoic acid involves cleavage of the transmembrane ligand HBEGF by ADAM 10."}, {"pubmed": 12612909, "text": "Transgenic expression of HB-EGF accelerates the proliferation of hepatocytes after partial hepatectomy"}, {"pubmed": 12725245, "text": "the effect of N- and C-terminal residues of the EGF-like domain of HB-EGF in the binding affinity to the EGF receptor on A431 cells"}, {"pubmed": 12768307, "text": "Diffusely expressed throughout normal and psoriatic epidermis and sparsely colocalized with EGFr in all viable epidermal layers, with increased colocalization in psoriatic epidermis."}, {"pubmed": 12835543, "text": "HB-EGF has an important role in the early pathogenesis of psoriasis."}, {"pubmed": 12882762, "text": "HB-EGF and FGF-2 act in concert to regulate the synthesis of elastin in injury/repair situations in pulmonary fibroblasts."}, {"pubmed": 12952982, "text": "proHB-EGF shedding induced by TPA and angiotensin II requires PACSIN3 as an upregulator"}, {"pubmed": 12958167, "text": "Heparin-binding EGF-like growth factor has a role in Angiopoietin-mediated recruitment of vascular smooth muscle cells."}, {"pubmed": 14573593, "text": "GnRH-induced transactivation of the EGF-R and the subsequent ERK1/2 phosphorylation result from ectodomain shedding of HBEGF."}, {"pubmed": 14634113, "text": "HB-EGF blocks cytokine-induced NF-kappaB activation and decreases nitric oxide production, interferes with cytokine-induced IkappaB kinase activity, inhibits phosphorylation and degradation of IkappaBalpha, and suppresses release of proinflammatory IL-8."}, {"pubmed": 14738873, "text": "Results suggest that epidermal growth factor receptor HER-mediated autocrine and paracrine signaling by heparin-binding EGF-like growth factor or other EGF family members induces cytotrophoblast differentiation to an invasive phenotype."}, {"pubmed": 14764442, "text": "Cis-acting element mediating gastrin responsiveness was mapped to the -69 to -58 region of the HB-EGF promoter. Gastrin stimulation was PKC dependent and at least partially mediated by activation of the EGF receptor."}, {"pubmed": 15062539, "text": "The spatial and temporal pattern of HB-EGF expression suggest that HB-EGF may an important local regulator of ovarian function and structure."}, {"pubmed": 15169883, "text": "relevance of a p38-ADAM-HB-EGF-EGFR-dependent pathway and its potential significance for tumor cells in evasion of chemotherapeutic agent-induced apoptosis"}, {"pubmed": 15274392, "text": "HB-EGF might be a more important tumor growth regulator of malignant fibrous histiocytoma through autocrine or paracrine pathways, when compared with betacellulin."}, {"pubmed": 15289334, "text": "HB-EGF is a potent inducer of tumor growth and angiogenesis"}, {"pubmed": 15331606, "text": "the heparin-binding domain serves as a negative regulator of heparin-binding EGF-like Growth Factor"}, {"pubmed": 15389565, "text": "Results indicate that pro-heparin-binding EGF-like growth factor (pro-HB-EGF) shedding and subsequent HB-EGF C terminal fragment signaling are related with progression of the cell cycle."}, {"pubmed": 15509542, "text": "ADAM12m is highly expressed in human glioblastomas and may play a role in the prominent proliferation of the glioblastomas through shedding of heparin-binding epidermal growth factor"}, {"pubmed": 15562026, "text": "HB-EGF has a function in endometrial maturation in mediating decidualization and attenuating TNF alpha- and TGF beta-induced apoptosis of endometrial stromal cells."}, {"pubmed": 15755902, "text": "HB-EGF/HER-1 signaling is relevant to mesenchymal stem cell biology, by regulating both proliferation and differentiation"}, {"pubmed": 15827558, "text": "These results suggested that HB-EGF in peritoneal fluid might play a key role in cell survival and in the proliferation of OVCA."}, {"pubmed": 15979989, "text": "HB-EGF may play a vital role in regulating luteal growth in a juxtacrine manner and through activating HER4 signalling"}, {"pubmed": 15988409, "text": "HB-EGF is one of the factors that are significantly upregulated in PVR (proliferative vitreoretinopathy) retinas."}, {"pubmed": 16034135, "text": "Recombinant HB-EGF decreases proinflammatory cytokine-stimulated NF-kappa B activation and nitric oxide production via activation of the phosphoinositide-3-kinase signaling pathway."}, {"pubmed": 16407398, "text": "A post-transcriptional mechanism induced in trophoblasts by low O(2) rapidly amplifies HBEGF signaling to inhibit apoptosis."}, {"pubmed": 16470170, "text": "HB-EGF and amphiregulin mediate retinoic-acid induced epidermal hyperplasia"}, {"pubmed": 16557002, "text": "results suggest a novel role for the cytoplasmic domain of HB-EGF that is regulated by phosphorylation"}, {"pubmed": 16687414, "text": "lysophosphatidic acid-induced IL-8 secretion is partly dependent on EGFR transactivation regulated by PKCdelta-dependent activation of Lyn kinase and MMPs and proHB-EGF"}, {"pubmed": 16837648, "text": "Inward potassium current in bladder urothelial cells(BUC) can be modulated by EGF and HB-EGF. Changes in BUC membrane potassium conductance caused by altered levels of EGF and HB-EGF may therefore play role in pathophysiology of interstitial cystitis."}, {"pubmed": 16901467, "text": "Glutamatergic neurotransmission plays a crucial role in regulating ectodomain shedding of transgenic HB-EGF in the brains of transgenic mice that overexpress human HB-EGF."}, {"pubmed": 16923819, "text": "Nardilysin has an essential role in HB-EGF ectodomain shedding, which is regulated by the modulation of sheddase activity"}, {"pubmed": 16996055, "text": "Results demonstrate that mRNA stability and in particular the heparin binding epidermal growth factor like growth factor (HB-EGF) 3'-untranslated region is involved in HB-EGF mRNA induction."}, {"pubmed": 17001310, "text": "Chemotherapy-induced HB-EGF activation represents a critical mechanism of inducible chemotherapy resistance."}, {"pubmed": 17392284, "text": "HB-EGF carboxyl-terminal fragment is a potent regulator of gene expression via its interaction with the transcriptional repressor Bcl6."}, {"pubmed": 17472728, "text": "These findings demonstrate that amino-terminally truncated, membrane-bound form of HB-EGF stimulates cell proliferation but lacks insulin-like signalling."}, {"pubmed": 17525275, "text": "HB-EGF is up-regulated in tumor cells of SCC but not BCC of the skin. HB-EGF is also overexpressed in asymptomatic epidermis adjacent to both SCC and BCC, relative to normal skin."}, {"pubmed": 17548351, "text": "Gbetagamma mediates UVB-induced human keratinocyte apoptosis by augmenting the ectodomain shedding of HB-EGF, which sequentially activates EGFR and p38"}, {"pubmed": 17637826, "text": "activation of PPARdelta is a major event in psoriasis, contributing to the hyperproliferative phenotype by induction of HB-EGF."}, {"pubmed": 17654528, "text": "The maintenance of the activation level of EGFR, which determines the cellular invasive potential, operates through an autocrine loop involving the JNK-dependent production of uPA and HB-EGF activity."}, {"pubmed": 17668298, "text": "Plasma/bladder concentrations of recombinant human rhHB-EGF equivalents were significantly lower following the intravesicular route than following intravenous administration. Histologic tissue examination indicated no toxicity attributable to rhHB-EGF."}, {"pubmed": 17717322, "text": "HB-EGF regulated epithelial repair is enhanced by IL-13 from airway epithelial cells"}, {"pubmed": 17855771, "text": "Juxtacrine activation of EGFR by membrane-anchored HB-EGF may play an important role in the regulation of tight junction proteins and transepithelial resistance."}, {"pubmed": 17928891, "text": "alters the phenotype of keratinocytes in a manner similar to that observed during epidermal repair"}, {"pubmed": 17960400, "text": "TNFalpha may play a key role in cooperation with HB-EGF and AREG in the proliferation of epidermal keratinocytes at the psoriatic skin lesions."}, {"pubmed": 17962208, "text": "HBEGF was present in almost all breast cancers studied. High expression is related to the biological aggressiveness of breast cancer."}, {"pubmed": 18093224, "text": "HB-EGF acts as a negative adipogenesis regulator during the early but not later stages of adipocyte differentiation, block the commitment of pluripotent mesenchymal cells to the adipocyte lineage triggered by bone morphogenic protein 4."}, {"pubmed": 18463770, "text": "Review. HB-EGF is implicated in angiogenesis, wound healing, blastocyst implantation, atherosclerosis, & tumor formation. It is the diphtheria toxin receptor."}, {"pubmed": 18686008, "text": "A novel hairless model on an atopic dermatitis-prone genetic background generated by DTR transgenesis is reported."}, {"pubmed": 18691754, "text": "HBEGF-mediated signaling significantly reduces trophoblast cell death at term and its deficiency in preeclampsia could negatively impact trophoblast survival."}, {"pubmed": 18725202, "text": "These results suggest that HB-EGF-Cys/Ser(134/143) antagonizes EGFRs."}, {"pubmed": 18852147, "text": "The roles of HB-EGF in cell adhesion, invasion, and angiogenesis in ovarian cancer, were examined."}, {"pubmed": 18925469, "text": "HB-EGF regulates endothelial cell function via stimulation of eNOS and nitric oxide production to promote eNOS dependent angiogenesis."}, {"pubmed": 18929421, "text": "Pro-inflammatory stimuli induce the release of HB-EGF from mesenchyme cells, which stimulates DNA-replication in initiated/premalignant hepatocytes"}, {"pubmed": 19064678, "text": "At least three genes, orthologous to loci in this LD block, HBEGF, IK, and SRA1, result independently in a phenotype of myocardial contractile dysfunction when their expression is reduced with morpholino antisense reagents."}, {"pubmed": 19127210, "text": "Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis."}, {"pubmed": 19218109, "text": "Increased HB-EGF expression may be implicated in the pathogenesis and development of gastric carcinoma."}, {"pubmed": 19389413, "text": "HBEGF is a potent dilator of terminal mesenteric arterioles."}, {"pubmed": 19559571, "text": "These results demonstrate that HB-EGF-induced eNOS activation depends on p42/p44 MAPK, PI3K/Akt pathways and endogenous VEGF in HaCaT cells."}, {"pubmed": 19609315, "text": "lentivirus-mediated expression of soluble HB-EGF, but not soluble amphiregulin, strongly enhanced keratinocyte migration, even in the presence of metalloproteinase inhibitors"}, {"pubmed": 19671876, "text": "Measuring HIF1a, HB-EGF, and VEGF-C expression may contribute to a better understanding of the prognosis of patients with soft tissue sarcoma and may even play a crucial role for the distribution of patients to multimodal therapeutic regimens."}, {"pubmed": 19682489, "text": "Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19919524, "text": "This data suggests that ethanol-induced apoptosis was reduced by HB-EGF, while hESC pluripotency was maintained."}, {"pubmed": 19961362, "text": "Increased serum HB-EGF is associated with heart hypertrophy and elevated blood cholesterol."}, {"pubmed": 19996587, "text": "We demonstrated that human adrenocortical carcinoma cells express HB-EGF"}, {"pubmed": 20130271, "text": "HBEGF advances trophoblast extravillous differentiation through coordinate activation of PI3 kinase, ERK, MAPK14, and JNK, while only MAPK14 is required for its antiapoptotic activity."}, {"pubmed": 20131286, "text": "reduction of antiphospholipid-mediated HB-EGF represents an mechanism that is responsible for the defective placentation and heparin protects from aPL-induced damage by inhibiting antibody binding"}, {"pubmed": 20332144, "text": "mAbs efficiently inhibited ectodomain shedding of proHB-EGF, and consequently prevented the cell growth of the EGFR-expressing cells in a co-culture system with proHB-EGF-expressing cells."}, {"pubmed": 20351696, "text": "induces several genes characteristics of columnar phenotypes of esophageal squamous epithelium in a paracrine manner"}, {"pubmed": 20424473, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20586269, "text": "HB-EGF participate in transactivation of EGF receptor under oxidative stress."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20739660, "text": "Endothelial-derived PDGFB and HBEGF both are required to control pericyte motility, proliferation, and recruitment along the endothelial cell tube ablumenal surface."}, {"pubmed": 20847549, "text": "Recombinant HB-EGF significantly promotes rat PC12 cell neurite outgrowth, an effect blocked by EGF receptor (EGFR) inhibition or mitogen-activated protein kinase (MAPK) inhibition, but not by tyrosine kinase inhibition."}, {"pubmed": 20856931, "text": "Expression of HB-EGF is regulated by miR-212 in head and neck squamous cell carcinoma."}, {"pubmed": 20889674, "text": "Results suggest that LTD induces EGF receptor transactivation through the release of HB-EGF in human bronchial epithelial cells with downstream release of CXCL8."}, {"pubmed": 20946474, "text": "MT1-MMP co-expressed with HB-EGF in ovarian carcinoma cells potentiates the activity of HB-EGF to promote invasive tumor growth and spreading in vivo."}, {"pubmed": 21386996, "text": "PKCalpha and PKCdelta regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways."}, {"pubmed": 21413023, "text": "ATP induces HB-EGF synthesis and release by interacting with the P2 purinergic receptor and through p38 and ERK1/2 signaling in response to a challenging environment."}, {"pubmed": 21640162, "text": "brief exposure to HB-EGF, but not to EGF, is sufficient to induce prolonged activation of the EGF receptor and to enhance healing"}, {"pubmed": 21788507, "text": "Hypoxic induction of PAR-2 was found to elicit an angiogenic endothelial cell phenotype and to specifically up-regulate heparin-binding EGF-like growth factor (HB-EGF)."}, {"pubmed": 22009535, "text": "findings indicate that HB-EGF and PDGF reciprocally mediate the interaction of cancer cells with cancer-associated fibroblasts, promoting cancer cell proliferation in a paracrine manner"}, {"pubmed": 22110740, "text": "LIV-1 is involved in prostate cancer progression as an intracellular target of growth factor receptor signaling which promoted EMT and cancer metastasis"}, {"pubmed": 22136955, "text": "These results confirm that polymorphisms in the HGEGF gene are associated with pre-eclampsia."}, {"pubmed": 22209887, "text": "Heparin-binding epidermal growth factor-like growth factor is a potent autocrine regulator of invasion activity in oral squamous cell carcinoma."}, {"pubmed": 22291012, "text": "Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor."}, {"pubmed": 22319602, "text": "variant 1936T prevents hsa-miR-1207-5p from down-regulating HBEGF in podocytes"}, {"pubmed": 22402363, "text": "study is the first report demonstrating a role for the ADAM-HBEGF-EGF receptor axis in Ox-PAPC induction of IL-8 in HAECs."}, {"pubmed": 22592159, "text": "expression of HB-EGF in human KCs triggers a migratory and invasive phenotype with many features of epithelial-mesenchymal transition (EMT), which may be beneficial in the context of cutaneous wound healing."}, {"pubmed": 22646534, "text": "HB-EGF-C nuclear translocation might be crucial in gastric cancer invasion. HB-EGF-C nuclear translocation may offer a prognostic marker and a new molecular target for gastric cancer therapy."}, {"pubmed": 22718294, "text": "Results suggest that heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) is a target for oral cancer and that CRM197 is effective in oral cancer therapy."}, {"pubmed": 23146907, "text": "results indicate that Abl kinases negatively regulate HNSCC invasive processes through suppression of an HB-EGF autocrine loop responsible for activating a EGFR-Src-cortactin cascade"}, {"pubmed": 23349913, "text": "Our results show that HB-EGF acts as a cell proliferation and cell survival factor in cancer cells."}, {"pubmed": 23376846, "text": "HB-EGF overexpression and Kras(G12D) together, but neither alone, increase cancer cell proliferation."}, {"pubmed": 23443317, "text": "Results suggest that HB-EGF plays a pivotal role in the acquisition of tumor aggressiveness in TNBC by orchestrating a molecular hierarchy regulating tumor angiogenesis."}, {"pubmed": 23589494, "text": "Hypoxia increased the levels and activity of the ADAM12 metalloprotease in a Notch signaling-dependent manner, leading to increased ectodomain shedding of the epidermal growth factor (EGF) receptor (EGFR) ligand heparin-binding EGF-like growth factor."}, {"pubmed": 23597914, "text": "Correlation has been found between HB-EGF expression/immunostaining and the different types of analyzed soft tissue sarcomas."}, {"pubmed": 23598347, "text": "visualized spatiotemporal regulation of proHB-EGF shedding in individual cells using a simple method that measures changes in fluorescence ratios"}, {"pubmed": 23787814, "text": "A reciprocal cross-talk between intrahepatic cholangiocarcinoma cells and myofibroblasts through the HB-EGF/EGFR axis contributes to CCA progression."}, {"pubmed": 23907942, "text": "The study suggest that one of the causes of unexplained miscarriages may result from the impaired expression of heparanase and heparin-binding EGF-like growth factor."}, {"pubmed": 23917679, "text": "HB-EGF acts as a potent paracrine and/or autocrine chemotactic factor as well as a mitogen that mediates HER1 and/or HER4 in the invasion and metastasis of thyroid carcinoma cells."}, {"pubmed": 24013225, "text": "Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo."}, {"pubmed": 24038577, "text": "Heparin-binding epidermal growth factor and CD9 are likely implicated in processes that are highly relevant for MS lesion formation"}, {"pubmed": 24043629, "text": "a mechanism of a probiotic-derived soluble protein in modulating intestinal epithelial cell homeostasis through ADAM17-mediated HB-EGF release, leading to transactivation of EGFR."}, {"pubmed": 24116709, "text": "studies suggest disintegrin and metalloproteinase domain-containing protein 12(ADAM 12S) and heparin-binding epidermal growth factor-like growth factor(HB-EGF) are involved in cellular plasticity resulting in production of brown adipose tissue-like cells"}, {"pubmed": 24346967, "text": "Knockdown of HSP27 by shRNA decreased HB-EGF plus CXCL5-mediated tumor spheroid formation in a three-dimensional culture system, suggesting that AKT/HSP27 was required for HB-EGF/CXCL5-mediated cancer progression"}, {"pubmed": 24828490, "text": "HB-EGF is a biomarker for LPA1 receptor activation in human breast and prostate cancers."}, {"pubmed": 25138066, "text": "the relative expression of hyalurosome (CD44, HAS3, HB-EGF) genes was found to be reduced in patients prior to topical treatment and to be notably increased following treatment."}, {"pubmed": 25201063, "text": "MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF."}, {"pubmed": 25359857, "text": "Suggest high levels of HB-EGF contribute to carotid plaque stabilization and reduce the incidence of acute coronary events."}, {"pubmed": 25510766, "text": "Urinary levels of NGF and HB-EGF may be potential biomarkers for evaluating outcome of overactive bladder syndrome treatment."}, {"pubmed": 25517307, "text": "Studies indicate that heparin-binding EGF-like growth factor (HB-EGF) is a therapeutic target in some types of cancers."}, {"pubmed": 25589361, "text": "Data suggest that placental expression of HBEGF, EGF (epidermal GF), and TGFA (transforming GF alpha) is down-regulated in pre-eclampsia as compared to normal term birth; each growth factor blocks cell death/apoptosis of cytotrophoblast cell line."}, {"pubmed": 25717241, "text": "Serum sHB-EGF is closely correlated with advanced stage gastric cancer and can be a promising serological biomarker for GC."}, {"pubmed": 26572150, "text": "HB-EGF is a molecular target for the resistance of ovarian cancer to paclitaxel and CRM197 as a HB-EGF-targeted agent might be a chemosensitizing agent for paclitaxel-resistant ovarian carcinoma"}, {"pubmed": 26974561, "text": "These results indicate that this new anti-HB-EGF mAb 2-108 would be useful in the diagnosis of HB-EGF-related cancers and would be a strong tool in both basic and clinical research on HB-EGF."}, {"pubmed": 26980026, "text": "Serous carcinomatous component championed by expression of HB-EGF predisposes to recurrence/metastasis in stage I metastasis and recurrence in stage I uterine malignant mixed mullerian tumor."}, {"pubmed": 27097072, "text": "This antibody reacts with human HB-EGF but not mouse HB-EGF. No cross-reactivity to other EGFR ligands was observed by antigen ELISA."}, {"pubmed": 27243144, "text": "Results support the idea that excess heparin binding epidermal growth factor-like growth factor (HB-EGF) leads to a significant elevation of vascular endothelial growth factor (VEGF) and ventricular dilatation. These data suggest a potential pathophysiological mechanism that elevated HB-EGF can elicit VEGF induction and hydrocephalus."}, {"pubmed": 27496793, "text": "Annexin A2 and HB-EGF are overexpressed and are being secreted into serum in Her-2 negative breast cancer patients."}, {"pubmed": 27701455, "text": "Study demonstrates that HBEGF is post-transcriptionally regulated by low O2 (placental environment) through a mechanism involving interactions of miRNAs with its 3'UTR."}, {"pubmed": 27888810, "text": "macrophage-secreted MMP-9 released HB-EGF from macrophages, which increased MMP9 in OVCA433, resulting in a positive feedback loop to drive HB-EGF release and increase proliferation in co-culture."}, {"pubmed": 28013056, "text": "MMP14 plays an important mechanistic role in NSCLC progression, by supporting cancer invasiveness, promoting collagen degradation, and releasing HB-EGF, which accelerates lung tumor progression."}, {"pubmed": 28174207, "text": "Heparan sulfate proteoglycans and heparin derivatives further enhance HBEGF-induced differentiation by forming a complex with the epidermal growth factor receptor"}, {"pubmed": 28183528, "text": "Genome-wide significant (GWS) associations in single-nucleotide polymorphism (SNP)-based tests (P < 5 x 10(-8)) were identified for SNPs in PFDN1/HBEGF, USP6NL/ECHDC3, and BZRAP1-AS1."}, {"pubmed": 28368403, "text": "this study suggests that HBEGF promotes the formation of gliomas, is necessary for tumor maintenance and therefore may be a novel therapeutic target."}, {"pubmed": 28498437, "text": "These results suggest that HBEGF is an important EGFR ligand in cervical cancer and that cervical cancer cells are the predominant source of HBEGF. Therefore, we propose an autocrine EGFR stimulation model in cervical carcinomas."}, {"pubmed": 28668900, "text": "Results show that HBEGF is highly expressed in primary ovarian tumors and increases as the disease progresses."}, {"pubmed": 28731464, "text": "both HBEGF upregulation and apoptosis were rescued by exogenous MMP2"}, {"pubmed": 28746898, "text": "levels of the angiogenesis mediators endoglin, HB-EGF, BMP-9 and FGF-2 in patients with severe sepsis and septic shock; endoglin and HB-EGF could be involved in the host response of sepsis; additional studies are warrant to investigate their role as biomarker or therapeutic targets in sepsis"}, {"pubmed": 28953531, "text": "Screening for HB-EGF SNPs/genotypes and plasma levels may be useful as a risk factor for necrotizing enterocolitis in the future."}, {"pubmed": 28970067, "text": "HB-EGF is implicated in DNA double strand breaks repair as silencing of HB-EGF increased gammaH2AX foci half-life as well as USP9X expression, two features that could be linked to the observed effect on Mcl-1."}, {"pubmed": 29044628, "text": "HB-EGF plays a pro-inflammatory role in the active skin and lung lesions of systemic sclerosis."}, {"pubmed": 29502423, "text": "ALphaHB-EGF LNP is a promising carrier for the treatment of HB-EGF-expressing cancers, including triple-negative breast cancer."}, {"pubmed": 29581578, "text": "Sputum and lung tissue HB-EGF expression was evaluated in control subjects and patients with COPD. There was a significant positive correlation between sputum HB-EGF and COPD assessment test score. HB-EGF expression was significantly increased in the lung tissue samples of patients with COPD and associated with collagen deposition and N- and E-cadherin, and vimentin expression."}, {"pubmed": 29970572, "text": "HB-EGF expression in serum may be a potential therapeutic indicator for novel HB-EGF-targeted therapy in recurrent ovarian cancer."}, {"pubmed": 30285805, "text": "Gene expression analysis suggests a role of basic helix-loop-helix protein 40 (BHLHE40) in transcriptional activation of heparin-binding epidermal growth factor (HBEGF)."}, {"pubmed": 30415904, "text": "Protein immunostaining was statistically significantly higher for HIF-1alpha, ADAM12, HB-EGF, and NOTCH 1 in mucoepidermoid carcinoma samples than in the control group, and the proteins were especially overexpressed in epidermoid cells of mucoepidermoid carcinoma"}, {"pubmed": 30451982, "text": "Review of heparin binding EGF like growth factor's role in epithelial to mesenchymal transition in chronic obstructive pulmonary disease."}, {"pubmed": 30610007, "text": "Two novel variants of ADAM17 identified in tetralogy of Fallot patients can induce cardiac myocyte hypertrophy via HB-EGF/ErbB signaling."}, {"pubmed": 31036568, "text": "Data demonstrate that soluble HB-EGF is an endogenous regulator of muscle Galgt2 gene expression and can mimic Galgt2-dependent muscle phenotypes."}, {"pubmed": 31799884, "text": "Circulating levels of inflammatory parameters pentraxin-3, cyclophilin and heparin-binding epidermal growth factor-like growth factor in patients with ST-elevation myocardial infarction."}, {"pubmed": 31882563, "text": "Findings identify a novel glucose/HB-EGF/EGFR axis implicated in beta-cell compensation to increased metabolic demand."}, {"pubmed": 32077785, "text": "Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases."}, {"pubmed": 32296111, "text": "s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide."}, {"pubmed": 32627036, "text": "M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HBEGF."}, {"pubmed": 33009641, "text": "APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis."}, {"pubmed": 33400994, "text": "Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients."}, {"pubmed": 34475044, "text": "Soluble Factors Involved in Cancer Cell-Macrophage Interaction Promote Breast Cancer Growth."}, {"pubmed": 34814928, "text": "microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor."}, {"pubmed": 36261438, "text": "HBEGF-TNF induce a complex outer retinal pathology with photoreceptor cell extrusion in human organoids."}, {"pubmed": 37567873, "text": "Spinal cord repair is modulated by the neurogenic factor Hb-egf under direction of a regeneration-associated enhancer."}, {"pubmed": 38409259, "text": "The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology."}], "genomic_pos": {"chr": "5", "end": 140346603, "ensemblgene": "ENSG00000113070", "start": 140332843, "strand": -1}, "genomic_pos_hg19": {"chr": "5", "end": 139726216, "start": 139712428, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 1840698, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007173", "qualifier": "involved_in", "term": "epidermal growth factor receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007173", "pubmed": 8702723, "qualifier": "involved_in", "term": "epidermal growth factor receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007173", "pubmed": 17655843, "qualifier": "involved_in", "term": "epidermal growth factor receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007517", "pubmed": 8347598, "qualifier": "involved_in", "term": "muscle organ development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008016", "qualifier": "involved_in", "term": "regulation of heart contraction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0008284", "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030307", "qualifier": "involved_in", "term": "positive regulation of cell growth"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030335", "pubmed": 17655843, "qualifier": "involved_in", "term": "positive regulation of cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035313", "qualifier": "involved_in", "term": "wound healing, spreading of epidermal cells"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0038134", "qualifier": "involved_in", "term": "ERBB2-EGFR signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0038135", "qualifier": "involved_in", "term": "ERBB2-ERBB4 signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048661", "qualifier": "involved_in", "term": "positive regulation of smooth muscle cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050731", "qualifier": "involved_in", "term": "positive regulation of peptidyl-tyrosine phosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051545", "qualifier": "involved_in", "term": "negative regulation of elastin biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051549", "qualifier": "involved_in", "term": "positive regulation of keratinocyte migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051897", "pubmed": 17655843, "qualifier": "involved_in", "term": "positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060326", "pubmed": 24008408, "qualifier": "involved_in", "term": "cell chemotaxis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090303", "pubmed": 17655843, "qualifier": "involved_in", "term": "positive regulation of wound healing"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 8702723, "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 12743035, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005615", "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005615", "pubmed": 15389565, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "pubmed": 15389565, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 12743035, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0009986", "pubmed": 15289334, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0030666", "qualifier": "located_in", "term": "endocytic vesicle membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0030669", "qualifier": "located_in", "term": "clathrin-coated endocytic vesicle membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005154", "qualifier": "enables", "term": "epidermal growth factor receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [9135143, 28988771, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008083", "qualifier": "enables", "term": "growth factor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008083", "pubmed": 12070119, "qualifier": "enables", "term": "growth factor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008201", "qualifier": "enables", "term": "heparin binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0008201", "pubmed": 8300582, "qualifier": "enables", "term": "heparin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0030297", "pubmed": 8702723, "qualifier": "enables", "term": "transmembrane receptor protein tyrosine kinase activator activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0048018", "pubmed": 8702723, "qualifier": "enables", "term": "receptor ligand activity"}]}, "homologene": {"genes": [[9031, 395654], [9544, 695559], [9598, 735979], [9606, 1839], [9615, 607007], [9913, 522921], [10090, 15200], [10116, 25433]], "id": 1466}, "interpro": {"desc": "EGF-like domain", "id": "IPR000742", "short_desc": "EGF-like_dom"}, "ipi": "IPI00012948", "map_location": "5q31.3", "name": "heparin binding EGF like growth factor", "other_names": ["diphtheria toxin receptor (heparin-binding EGF-like growth factor)", "diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor)", "heparin-binding epidermal growth factor", "proheparin-binding EGF-like growth factor"], "pantherdb": {"HGNC": "3059", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "96070", "ortholog_type": "LDO", "panther_family": "PTHR10740", "taxid": 10090, "uniprot_kb": "Q06186"}, {"RGD": "2526", "ortholog_type": "LDO", "panther_family": "PTHR10740", "taxid": 10116, "uniprot_kb": "Q06175"}, {"Ensembl": "ENSGALG00000000949", "ortholog_type": "LDO", "panther_family": "PTHR10740", "taxid": 9031, "uniprot_kb": "Q9W7C5"}, {"ZFIN": "ZDB-GENE-070820-6", "ortholog_type": "O", "panther_family": "PTHR10740", "taxid": 7955, "uniprot_kb": "A0A2R8RUB3"}, {"ZFIN": "ZDB-GENE-080204-119", "ortholog_type": "LDO", "panther_family": "PTHR10740", "taxid": 7955, "uniprot_kb": "A9JRW9"}], "uniprot_kb": "Q99075"}, "pathway": {"biocarta": {"id": "nfatpathway", "name": "nfat and hypertrophy of the heart "}, "kegg": [{"id": "hsa04012", "name": "ErbB signaling pathway - Homo sapiens (human)"}, {"id": "hsa04912", "name": "GnRH signaling pathway - Homo sapiens (human)"}, {"id": "hsa04915", "name": "Estrogen signaling pathway - Homo sapiens (human)"}, {"id": "hsa04928", "name": "Parathyroid hormone synthesis, secretion and action - Homo sapiens (human)"}, {"id": "hsa05120", "name": "Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}, {"id": "hsa05205", "name": "Proteoglycans in cancer - Homo sapiens (human)"}, {"id": "hsa05219", "name": "Bladder cancer - Homo sapiens (human)"}], "pid": [{"id": "er_nongenomic_pathway", "name": "Plasma membrane estrogen receptor signaling"}, {"id": "erbb4_pathway", "name": "ErbB4 signaling events"}, {"id": "erbb_network_pathway", "name": "ErbB receptor signaling network"}, {"id": "lysophospholipid_pathway", "name": "LPA receptor mediated events"}], "reactome": [{"id": "R-HSA-1227986", "name": "Signaling by ERBB2"}, {"id": "R-HSA-1227986", "name": "Signaling by ERBB2"}, {"id": "R-HSA-1227990", "name": "Signaling by ERBB2 in Cancer"}, {"id": "R-HSA-1236394", "name": "Signaling by ERBB4"}, {"id": "R-HSA-1236394", "name": "Signaling by ERBB4"}, {"id": "R-HSA-1250196", "name": "SHC1 events in ERBB2 signaling"}, {"id": "R-HSA-1250196", "name": "SHC1 events in ERBB2 signaling"}, {"id": "R-HSA-1250342", "name": "PI3K events in ERBB4 signaling"}, {"id": "R-HSA-1250347", "name": "SHC1 events in ERBB4 signaling"}, {"id": "R-HSA-1251985", "name": "Nuclear signaling by ERBB4"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-1643713", "name": "Signaling by EGFR in Cancer"}, {"id": "R-HSA-177929", "name": "Signaling by EGFR"}, {"id": "R-HSA-179812", "name": "GRB2 events in EGFR signaling"}, {"id": "R-HSA-180292", "name": "GAB1 signalosome"}, {"id": "R-HSA-180336", "name": "SHC1 events in EGFR signaling"}, {"id": "R-HSA-182971", "name": "EGFR downregulation"}, {"id": "R-HSA-1963640", "name": "GRB2 events in ERBB2 signaling"}, {"id": "R-HSA-1963642", "name": "PI3K events in ERBB2 signaling"}, {"id": "R-HSA-199418", "name": "Negative regulation of the PI3K/AKT network"}, {"id": "R-HSA-199991", "name": "Membrane Trafficking"}, {"id": "R-HSA-212718", "name": "EGFR interacts with phospholipase C-gamma"}, {"id": "R-HSA-2179392", "name": "EGFR Transactivation by Gastrin"}, {"id": "R-HSA-2179392", "name": "EGFR Transactivation by Gastrin"}, {"id": "R-HSA-2219528", "name": "PI3K/AKT Signaling in Cancer"}, {"id": "R-HSA-2219530", "name": "Constitutive Signaling by Aberrant PI3K in Cancer"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-416476", "name": "G alpha (q) signalling events"}, {"id": "R-HSA-416476", "name": "G alpha (q) signalling events"}, {"id": "R-HSA-5336415", "name": "Uptake and function of diphtheria toxin"}, {"id": "R-HSA-5339562", "name": "Uptake and actions of bacterial toxins"}, {"id": "R-HSA-5638302", "name": "Signaling by Overexpressed Wild-Type EGFR in Cancer"}, {"id": "R-HSA-5638303", "name": "Inhibition of Signaling by Overexpressed EGFR"}, {"id": "R-HSA-5653656", "name": "Vesicle-mediated transport"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6785631", "name": "ERBB2 Regulates Cell Motility"}, {"id": "R-HSA-6811558", "name": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"}, {"id": "R-HSA-881907", "name": "Gastrin-CREB signalling pathway via PKC and MAPK"}, {"id": "R-HSA-881907", "name": "Gastrin-CREB signalling pathway via PKC and MAPK"}, {"id": "R-HSA-8847993", "name": "ERBB2 Activates PTK6 Signaling"}, {"id": "R-HSA-8848021", "name": "Signaling by PTK6"}, {"id": "R-HSA-8856825", "name": "Cargo recognition for clathrin-mediated endocytosis"}, {"id": "R-HSA-8856828", "name": "Clathrin-mediated endocytosis"}, {"id": "R-HSA-8857538", "name": "PTK6 promotes HIF1A stabilization"}, {"id": "R-HSA-8863795", "name": "Downregulation of ERBB2 signaling"}, {"id": "R-HSA-8939211", "name": "ESR-mediated signaling"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006927", "name": "Signaling by Non-Receptor Tyrosine Kinases"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9009391", "name": "Extra-nuclear estrogen signaling"}, {"id": "R-HSA-9634638", "name": "Estrogen-dependent nuclear events downstream of ESR-membrane signaling"}, {"id": "R-HSA-9664565", "name": "Signaling by ERBB2 KD Mutants"}, {"id": "R-HSA-9665686", "name": "Signaling by ERBB2 TMD/JMD mutants"}, {"id": "R-HSA-9824439", "name": "Bacterial Infection Pathways"}], "wikipathways": [{"id": "WP2828", "name": "Bladder cancer"}, {"id": "WP2865", "name": "IL1 and megakaryocytes in obesity"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP2884", "name": "NRF2 pathway"}, {"id": "WP3888", "name": "VEGFA-VEGFR2 Signaling Pathway"}, {"id": "WP516", "name": "Hypertrophy Model"}, {"id": "WP673", "name": "ErbB signaling pathway"}]}, "pdb": ["1XDT", "2M8S"], "pharmgkb": "PA27513", "pharos": {"target_id": 15411, "tdl": "Tbio"}, "pir": "A38432", "prosite": "PS50026", "reagent": {"CondMedia_CM_LibrAB": {"id": "GNF293138", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248643", "relationship": "is"}, {"id": "GNF248644", "relationship": "is"}, {"id": "GNF248645", "relationship": "is"}, {"id": "GNF248646", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF036039", "relationship": "weakly similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081796", "relationship": "is"}, {"id": "GNF081797", "relationship": "is"}, {"id": "GNF081798", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054666", "relationship": "is"}, {"id": "GNF059444", "relationship": "is"}, {"id": "GNF074835", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070239", "relationship": "is"}, {"id": "GNF070240", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF003870", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF334723", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098108", "relationship": "is"}, {"id": "GNF137763", "relationship": "is"}, {"id": "GNF149620", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000005.10", "NC_060929.1"], "protein": "NP_001936.1", "rna": "NM_001945.3", "translation": {"protein": "NP_001936.1", "rna": "NM_001945.3"}}, "reporter": {"HG-U133_Plus_2": ["203821_at", "222076_at", "244857_at", "38037_at"], "HG-U95Av2": "38037_at", "HTA-2_0": "TC05001854.hg.1", "HuEx-1_0": ["2878273", "2878288"], "HuGene-1_1": "8114572", "HuGene-2_1": "17000724"}, "summary": "Enables growth factor activity and heparin binding activity. Involved in several processes, including epidermal growth factor receptor signaling pathway; positive regulation of protein kinase B signaling; and positive regulation of wound healing. Located in cell surface and extracellular space. Implicated in glomerulosclerosis and perinatal necrotizing enterocolitis. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "HBEGF", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1539630"}, "unigene": ["Hs.592942", "Hs.799"], "uniprot": {"Swiss-Prot": "Q99075"}, "wikipedia": {"url_stub": "Heparin-binding EGF-like growth factor"}}